Ureteroscopic management of recurrent renal cystine calculi

BACKGROUND AND PURPOSE: Patients with recurrent cystine nephrolithiasis oftentimes require multiple procedures for stone removal. As the majority of cystine stones are resistant to the effects of shockwave lithotripsy, repeat percutaneous surgery is often required and may cause renal damage. Moreover, repeat percutaneous access may become more difficult as perinephric fibrosis develops. Small-caliber ureteroscopes along with the holmium laser now enable routine intrarenal ureteroscopic access to symptomatic renal stones. Herein, we present our experience in managing recurrent renal cystine calculi using flexible ureterorenoscopy and assess whether such an approach may be used as an alternative to percutaneous surgery in selected patients. PATIENTS AND METHODS: Three patients with large-volume (mean diameter 22 mm) renal cystine stones were managed with a 7.5F flexible ureterorenoscope combined with holmium laser lithotripsy to fragment the stones completely. RESULTS: The mean treatment time was 97 minutes, with successful fragmentation in all cases. Two of the three patients were completely stone free on follow-up intravenous urography, with the third patient having only small-volume residual fragments in a lower pole calix. All patients are currently asymptomatic and are being maintained on high oral fluid intake, urinary alkalization with potassium citrate, and alpha-mercaptopropionylglycine to reduce urinary cystine excretion. CONCLUSION: Flexible ureterorenoscopy with holmium laser lithotripsy provides a reasonable alternative for the management for recurrent cystine calculi in patients who are not candidates for repeat percutaneous procedures. Although it is time consuming, complete stone fragmentation, along with clearance of fragments, can be achieved in the majority of patients.     

The frequency-doubled double-pulse Neodym:YAG laser lithotripter (FREDDY) in lithotripsy of urinary stones. First clinical experience

Laser lithotripsy does not play an important role in urinary stone treatment, mostly due to ineffective fragmentation efficiency, and high purchase and maintenance costs. The aim of the following retrospective study was to show the clinical significance and efficiency of an innovative laser lithotripsy system for urinary stone treatment. Between November 1998 and October 1999, 48 patients were treated with the innovative frequency- doubled double-pulse Neodym: YAG laser lithotripter FREDDY. A total of 50 renal units were treated, 43 ureteroscopically, four ureterorenoscopically, three percutaneous-nephroscopically, and one bladder stone cystoscopically. With a median laser operation time of 5 min (range: 1-30 min) and a total procedure duration of 60 min (range: 15-180 min), a stone-free rate of upper ureteral stones of 62%, middle ureteral stones of 91% and distal ureteral stones of 100% were documented on the first day after treatment. In an observation period of 6 months, no complications were seen. In our experience Laser lithotripsy with FREDDY is an effective, simple and reliable method for the treatment of ureteral stones, with low purchase and maintenance costs. The extremely thin and highly flexible quartz fibre may extend the endoscopic spectrum to otherwise poorly accessible upper ureteral stones, the renal pelvis and renal calix stones. Therefore, a prospective validation study for comparison with ballistic lithotriptors is of great interest.     

A comparison of the FREDDY and holmium lasers during ureteroscopic lithotripsy

BACKGROUND AND OBJECTIVE: Two laser devices that are used today in endoscopic treatment of renal and ureteral calculi are the frequency-doubled double-pulse neodynium:YAG (FREDDY) and Holmium:YAG lasers. The mechanism of action of these lasers differs, thus conferring potentially different safety and efficacy profiles. The in vitro efficacy of these lasers in treating urinary stones has been explored, but to our knowledge no study compares the in vivo efficacy. The purpose of this study is to compare the stone-free and complication rates of the FREDDY and holmium lasers. STUDY DESIGN/MATERIALS AND METHODS: Subjects were included in the study (from January 2004 to September 2006) if they had adequate documentation of stone size and location, postoperative stone burden, and perioperative complications. Stone-free status was determined based on intraoperative findings and postoperative imaging. Complications included bleeding, ureteral perforation, any intraoperative event necessitating termination of the procedure, ureteral stricture, hydronephrosis, and admission to the hospital with a diagnosis related to the procedure. RESULTS: Sixty patients with adequate follow-up were identified. Thirty patients were treated with FREDDY and 30 patients with Holmium laser. Fisher's exact test was employed for statistical analysis. There was no significant difference in the average stone size between the FREDDY and Holmium groups, which were 6.7 mm and 6.1 mm, respectively. Stone-free rates in the FREDDY and Holmium groups were 76.7% and 93.3%, respectively, P = 0.149. The complication rates were 17.4% in the FREDDY group and 10% in the Holmium group, P = 0.667. CONCLUSION: The complication and stone-free rates did not significantly differ between the FREDDY and Holmium lasers, though there was a trend toward a higher stone-free rate and lower complication rate with the holmium laser. Holmium laser may be more effective than the FREDDY laser in fragmenting calcium oxalate monohydrate stones. The device and laser fiber costs were comparable.     

Endoscopic management of impacted ureteral stones using a small caliber ureteroscope and a laser lithotriptor

PURPOSE: We reviewed our experience with retrograde endoscopy using a small caliber ureteroscope and a laser lithotriptor in 104 consecutive patients with impacted ureteral stones and also analyzed the associated endoscopic findings. MATERIALS AND METHODS: From July 1993 to October 1999 we performed retrograde endoscopic treatment in 104 patients with impacted ureteral stones. Average maximum stone diameter was 15.2 mm. (range 2 to 110), and 9 patients had stones larger than 3 cm. Mean duration of impaction was more than 14 months and the longest was 10 years. We used 6.9Fr rigid or 6.9 to 7.5Fr flexible ureteroscopes and a pulsed dye laser or holmium:YAG laser lithotriptor. RESULTS: Of the 104 ureteral stones 100 (96.2%) were completely fragmented by a single endoscopic procedure. Although 1 uric acid stone could not be disintegrated by either the pulsed dye laser or electrohydraulic lithotripsy early in this series, it was discharged spontaneously 2 weeks after the procedure. Additional extracorporeal shock wave lithotripsy (ESWL*) was required in 3 patients who initially had stones larger than 3 cm. A month after treatment no patient had evidence of residual stones. Using adjuvant ESWL a 100% success rate was attained with minimal morbidity. Endoscopic observation revealed inflammatory polyps of the ureter in 22 patients (21.2%), and stricture adjacent to the stone in 16 (15. 4%). There were no significant complications. CONCLUSIONS: Using a small caliber ureteroscope and a laser lithotriptor we could treat the target stone in all 104 patients with adjuvant ESWL in 3 cases. Endoscopic lithotripsy seems to be effective first line therapy for chronically impacted stones which are frequently associated with chronic inflammation, polyps and strictures, and avoids the futile repetition of ESWL and problems related to the prolonged passage of stone fragments.     

Safety and Efficacy of the Alexandrite Laser for the Treatment of Renal and Ureteral Calculi

Objectives. To assess the safety and efficacy of the Alexandrite laser for intracorporeal lithotripsy of renal and ureteral stones in conjunction with ureterorenoscopy or percutaneous nephrostolithotomy.Methods. We retrospectively analyzed the records of 137 patients with 169 calculi in 143 renoureteral units who were treated with the Alexandrite laser via a retrograde (91.5%) or antegrade (8.5%) endoscopic approach.Results. Adequate intraoperative fragmentation of the stone was observed in 88.8% of the cases. No intraoperative complications were attributable to the laser. At a mean follow-up of 34 days, the overall stone-free rate was 74.4%. The stone-free rate for ureteral stones (n = 115) was 80%, whereas the stone-free rate for renal stones (n = 22) was only 44%. In the best subgroup of ureteral stones (10 mm or less in the distal ureter), the stone-free rate was 97.4%.Conclusions. The Alexandrite laser is a safe modality for intracorporeal lithotripsy and is highly effective for ureteral stones less than 10 mm in size.     

Retrograde transureteral approach: a safe and efficient treatment for recurrent cystine renal stones

Most patients presenting cystinuria require multiple urological procedures during their lifetime. In this kind of patients the availability of minimally invasive procedure represents an advantage of minimizing the cumulative morbidity of several repeated treatments. Herein we report our experience using ureterorenoscopy (URS) for the treatment of recurrent renal cystine stones. From 2003 to 2007, 10 patients (4 males and 6 females) with one or multiple recurrent renal cystine stones underwent URS. Overall, 21 procedures have been performed. Mean maximum diameter of stones was 11.2 mm (range 5–30 mm). Either 8–9.5 F semirigid or 7.9 F flexible ureteroscopes were used. In 6 cases, stones were removed using a basket; in 9 procedures laser lithotripsy with flexible scope was performed; in 6 cases renal calculi were pulled down in the ureter using flexible instrument and then shattered with laser introduced by semirigid instrument. Stone-free status was defined as the absence of any residual fragment. A complete stone clearance was obtained in 15 out of 21 procedures (71%). In 5 cases (24%) significant residual fragments occurred; in the remaining case (5%) URS was ineffective. In 5 out of these unsuccessful procedures, stone clearance was obtained with auxiliary treatments. The last patient has not been treated yet. No major complications occurred as a result of the procedures. URS offers excellent advantages in case of recurrent hard calculi such as cystine stones. Minimally invasive procedures allow satisfactory outcomes, improving patients’ quality of life.     

输尿管镜下气压弹道碎石术与钬激光碎石术治疗输尿管结石的比较

目的比较输尿管镜下气压弹道碎石术与钬激光碎石术治疗输尿管结石的疗效和安全性。方法总结应用输尿管镜技术治疗326例输尿管结石患者的临床资料，其中气压弹道碎石术176例，钬激光碎石术150例。结杲钬激光碎石术碎石率为96．6％，高于气压弹道碎石术的89．8％（P〈0．01）；钬激光碎石术平均排净时间为10d，短于气压弹道碎石术的21d（P〈0．01）；钬激光碎石组有11例发生血尿，气压弹道碎石有54例发生血尿。结论钬激光碎石术的有效率和安全性优于气压弹道碎石术。钬激光碎石是治疗输尿管结石的一种安全、高效的方法。     

气压弹道碎石术与钬激光碎石术治疗输尿管结石的比较

目的：比较经输尿管镜气压弹道碎石术与钬激光石术治疗输尿结石的疗效和安全性。方法：总结应用输尿管镜技术治疗285例尿管结石患者的临床资料,其中气压弹道碎石术145例,钬激光碎石术140例。结果钬激光碎石术单次手术碎石率为95．75,高于气压弹道碎石术的69．7％,P＜0．01;钬激光碎石术平均结石排净时间为18d,短于气压弹道碎石术的31d,P＜0．01;钬激光碎石组无明显并发症发生,气压弹道碎石组有5例发生穿孔。结论钬激光碎石术的有效率和安全性优于气压弹碎石术,钬激光碎石术是治疗输尿管结石的一种安全、有高效的方法。     

输尿管软镜钬激光碎石术治疗输尿管上段结石

目的 总结输尿管软镜结合钬激光治疗输尿管上段结石的疗效及并发症,探讨手术技巧.方法 38 例输尿管上段结石患者接受输尿管软镜钬激光碎石治疗,先使用8/9.8 F 输尿管硬镜探查患侧输尿管,置入导丝后留置输尿管软镜鞘,引入输尿管软镜,钬激光碎石,并使用套石篮套取出较大的结石碎屑.结果 35 例患者一期顺利碎石,3 例因输尿管狭窄难以置入输尿管软镜鞘,留置输尿管内支架2 周后再次手术成功.手术时间31~56 min,平均42 min.术后7 例患者发热,无其他严重并发症.术后1 个月拔除内支架,2 周后复查KUB,结石清除率92.1%.结论 输尿管软镜结合钬激光是处理输尿管上段结石的有效手段,即便输尿管结石进入肾内,也可一期处理,避免了额外的体外碎石操作.     

结石CT值测定联合输尿管软镜治疗大负荷肾结石

目的探讨输尿管软镜下单次碎石治疗CT值≤800 HU、直径≥2 cm的肾结石的有效性、安全性和可行性。方法2016年1月~2018年12月我科对30例CT值≤800 HU、直径≥2 cm的肾结石行输尿管软镜下碎石。术前常规放置输尿管支架管2周。全麻后放置输尿管软镜鞘,沿鞘置入F 9.8 Olympus电子输尿管软镜,插入200μm或365μm(结石位于肾盂者)钬激光光纤,钬激光碎石能量设置为1.0 J,频率20~30 Hz,逐步粉碎结石。粉碎后较大结石碎片套石网篮取出。术后留置输尿管支架管1根。结果30例均顺利放置镜鞘并置入输尿管软镜,一次进镜成功率100%。手术时间50~90 min,平均75 min。均无二次手术。28例手术成功,2例术后有残余结石(直径分别为8、10 mm),行体外冲击波碎石术后2~3周排出。5例术后发热,经加强抗炎输液对症处理后,体温降至正常。无输尿管穿孔、出血等并发症。术后住院2~4 d,平均2.4 d。术后随访1年,2例复发,3例发现肾结晶,无特殊处理。结论CT值≤800 HU的大负荷肾结石行输尿管软镜下碎石安全、有效、可行。     

Lasers in clinical urology: state of the art and new horizons

We present an overview of current and emerging lasers for Urology. We begin with an overview of the Holmium:YAG laser. The Ho:YAG laser is the gold standard lithotripsy modality for endoscopic lithotripsy, and compares favorably to standard electrocautery transurethral resection of the prostate for benign prostatic hyperplasia (BPH). Available laser technologies currently being studied include the frequency doubled double-pulse Nd:Yag (FREDDY) and high-powered potassium-titanyl-phosphate (KTP) lasers. The FREDDY laser presents an affordable and safe option for intracorporeal lithotripsy, but it does not fragment all stone compositions, and does not have soft tissue applications. The high power KTP laser shows promise in the ablative treatment of BPH. Initial experiments with the Erbium:YAG laser show it has improved efficiency of lithotripsy and more precise ablative and incisional properties compared to Ho:YAG, but the lack of adequate optical fibers limits its use in Urology. Thulium:YAG fiber lasers have also demonstrated tissue ablative and incision properties comparable to Ho:YAG. Lastly, compact size, portability, and low maintenance schedules of fiber lasers may allow them to shape the way lasers are used by urologists in the future.     

6/7.5 F输尿管镜联合输尿管导管负压吸引治疗输尿管上段结石216例报告

目的探讨应用6/7.5 F输尿管镜联合旁置输尿管导管负压吸引治疗输尿管上段结石的安全性及有效性。 方法回顾性分析深圳市前海蛇口自贸区医院2019年1月至2020年12月采用6/7.5 F输尿管镜联合旁置输尿管导管负压吸引配合钬激光碎石治疗输尿管上段结石患者216例的临床资料。留置5 F输尿管导管越过结石上方,连接负压吸引,应用200 μm钬激光击碎结石。 结果216例患者中,术中共209例输尿管镜成功到达结石下方位置,上镜成功率96.8%;18例因整体或大部分结石移位至肾盂,一期行输尿管软镜碎石,结石上移率8.3%;术后低热5例,高热1例,感染率2.7%;拔管后20例KUB提示有>4 mm结石残留,清石率90.7%;所有病例均无输尿管穿孔、黏膜撕脱、感染性休克等严重并发症。 结论6/7.5 F输尿管镜联合旁置输尿管导管负压吸引治疗输尿管上段结石安全、有效,可降低结石上移逃逸率,提高术后清石率,减少术后感染,临床效果确切。     

ccccc逆行输尿管软镜钬激光碎石术治疗孤立肾肾结石的疗效观察

目的 探讨输尿管软镜钬激光碎石术在治疗孤立肾肾结石中的临床应用价值.方法 回顾分析本院使用奥林巴斯电子输尿管软镜钬激光碎石处理的39例孤立肾肾结石患者的临床资料,其中肾盂肾盏多发性结石20例,孤立肾感染性结石4例,肾盏憩室内结石10例,肾盏嵌顿结石4例,多发性肾乳头黏膜下钙化1例.术中先行输尿管硬镜镜检,留置斑马导丝并放置F12～ 14输尿管扩张鞘后经鞘或直接沿斑马导丝入镜.软镜进入肾盂后首先镜下观察肾盂及上、中、下各盏并定位结石,根据结石位置选用365μm或200μm光纤,功率选择在0.5～1J、15～ 30Hz范围,以表面蚕蚀、周缘穿孔、中央穿孔等方法将结石完全粉碎2mm以内,若患者留置输尿管鞘,则以冲水引流、套石蓝取石等方法将结石取出或部分取出.所有患者常规留置DJ管2周,术后第1d拔除导尿管,术后2周拔除DJ管,术后4周常规复查泌尿系平片（KUB）或双肾CT平扫,评估结石排净率.残留结石≥4mm为有临床意义的结石残留.结果 本组39例患者34例成功置放输尿管鞘,输尿管镜鞘放置成功率87.2％,进镜成功率100％,术中寻找结石成功率100％.一期手术成功碎石33例,结石均排尽或残余结石＜4mm,无需进一步处理.另3例下盏憩室内结石,2例下盏结石,1例肾乳头黏膜下钙化结石/残石均≥4mm,辅助体外冲击波碎石或2期输尿管软镜手术.结论 输尿管软镜对比经皮肾镜,具有微创安全、手术并发症少的特点,而且几乎可以达到肾内集合系统所有位置,结合钬激光适合治疗各类孤立肾肾结石.     

逆行输尿管软镜钬激光碎石术治疗孤立肾肾结石的疗效观察

目的:探讨输尿管软镜钬激光碎石术在治疗孤立肾肾结石中的临床应用价值。方法：回顾分析本院使用奥林巴斯电子输尿管软镜钬激光碎石处理的39例孤立肾肾结石患者,其中肾盂肾盏多发性结石20例,孤立肾感染性结石4例,肾盏憩室内结石10例,肾盏嵌顿结石4例,多发性肾乳头黏膜下钙化1例。术中先行输尿管硬镜镜检,留置斑马导丝并放置F12～14输尿管扩张鞘后经鞘或直接沿斑马导丝入镜。软镜进入肾盂后首先镜下观察肾盂及上、中、下各盏并定位结石,根据结石位置选用365μm或200μm光纤,功率选择在0.5～1J、15～30Hz范围,以表面蚕蚀、周缘穿孔、中央穿孔等方法将结石完全粉碎2mm以内,若患者留置输尿管鞘,则以冲水引流、套石蓝取石等方法将结石取出或部分取出。所有患者常规留置DJ管2周,术后第1天拔除导尿管,术后2周拔除DJ管,术后4周常规复查泌尿系平片(KUB)或双肾CT平扫,评估结石排净率。残留结石≥4mm为有临床意义的结石残留。结果：本组39例患者34例成功置放输尿管鞘,输尿管镜鞘放置成功率87.2%,进镜成功率100%,术中寻找结石成功率100%。一期手术成功碎石33例,结石均排尽或残余结石<4mm,无需进一步处理。另3例下盏憩室内结石,2例下盏结石,1例肾乳头黏膜下钙化结石/残石均≥4mm,辅助体外冲击波碎石或2期输尿管软镜手术。结论：输尿管软镜对比经皮肾镜,具有微创安全,手术并发症少的特点,而且几乎可以达到所有肾内集合系统所有位置,结合钬激光适合治疗各类孤立肾肾结石。     

Clinical experience of extracorporeal shock wave lithotripsy for cystine calculi

Thirty patients (16 men and 14 women) with cystine urinary stones were treated by extracorporeal shock wave lithotripsy (Dormer HM-3) from December 1984 through October 1989. The average patient age was 35.2 years with a range of 14 to 59 years. Seventy per cent of these subjects had had previous open surgical operations for stones. The cases consisted of 7 ureteral stones and 37 renal stones, including 15 staghorn calculi. An average of 1.3 session of ESWL was carried out to treat ureteral stones. Thirty-seven renal units with renal stone required 96 sessions of lithotripsy (average 2.6 sessions per unit). Seven patients with ureteral stones required auxiliary procedures, i.e., one transurethral lithotripsy (TUL), two percutaneous nephrostomies (PNS) and one open surgery. Thirty-seven renal stones, including staghorn calculi was treated by ESWL and auxiliary treatment of 21 TUL procedures, one PNS, 16 PNL procedures and one chemical chemolysis. Successful fragmentation (residual debris less than or equal to 4 mm) was achieved in 85.7% of ureteral stones, 90.9% of renal stones and 73.3% of staghorn calculi. The stone free rates of patients with ureteral stones, renal stones and staghorn calculi were 71.4%, 50.0% and 53.5%, respectively, at 3 months after ESWL. No serious complications were seen in this series. Fever above 38.5 degrees C was the most common complications (13.5%). Ureteral perforation was encountered once in TUL procedures. Transfusion and selective arterial embolization were needed for one case treated by PNL procedures. Although cystine stone is harder to be fragmented by ESWL than other stone composition, ESWL and endourology may be effective and safe procedures for cystine stone patients.(ABSTRACT TRUNCATED AT 250 WORDS)     

输尿管硬镜下钬激光碎石取石术治疗输尿管上段结石112例

【摘要】〓目的〓探讨输尿管硬镜下钬激光碎石取石术治疗输尿管上段结石的临床效果及安全性。 方法〓应用输尿管硬镜下钬激光碎石取石术治疗112例输尿管上段结石患者。男63例,女49例,年龄18~87岁(46.7±13.6岁),左侧61例,右侧46例,双侧5例。结石长径0.7~2.2 cm(1.2±0.5 cm)。26例合并输尿管息肉,31例曾行体外冲击波碎石术,所有患侧肾脏均合并不同程度肾积水。 结果〓手术成功率88.4%(99/112),手术时间15~80 min(33.6±16.8 min),术后住院天数3~14天(4.7±2.1天)。所有患者均无严重肉眼血尿、输尿管穿孔、粘膜撕裂、输尿管镜石街形成等并发症。3例患者出现畏寒、高热,其中1例发展为尿源性脓毒血症,予以积极抗感染治疗后,症状逐渐缓解。结论〓输尿管硬镜下钬激光碎石取石术治疗输尿管上段结石是安全,有效的治疗方法。     

输尿管肾镜联合钬激光碎石术治疗输尿管结石

目的探讨经输尿管肾镜联合钬激光碎石术治疗输尿管结石的有效性及安全性。方法分析2005年1月至2006年12月收治的经输尿管肾镜钬激光治疗输尿管结石206例的临床资料。其中181例伴有患侧轻至中度肾盂积水,IVP患肾不显影19例,28例同时合并结石远端输尿管狭窄,57例合并有息肉或肉芽组织包裹,26例为体外冲击波碎石术(ESWL)治疗失败。结果206例中195例单次手术碎石成功,单次手术结石粉碎率达94.7%(195/206)。平均手术时间25min,术中无输尿管穿孔等并发症发生,平均住院日5.5d。10例结石在钬激光碎石过程中移位于肾盏或结石残留,术后再行ESWL治愈;1例双侧输尿管结石,因输尿管狭窄无法入镜,中转开放手术。结论输尿管肾镜联合钬激光碎石术治疗输尿管结石有效、安全,可作为输尿管结石特别是中下段结石首选的治疗方法。     

电子输尿管软镜钬激光碎石治疗复杂肾结石45例分析

目的探讨电子输尿管软镜钬激光碎石术在治疗复杂肾结石中的临床应用价值。方法回顾分析我科使用奥林巴斯电子输尿管软镜钬激光碎石处理的45例复杂肾结石患者,其中肾盂肾盏多发性结石23例（含10例孤立肾结石）,孤立肾感染性结石4例,肾盏憩室内结石11例,肾盏嵌顿结石4例,多发性肾乳头黏膜下钙化3例。术中先行输尿管硬镜镜检,留置斑马导丝并放置F12～14输尿管扩张鞘后经鞘或直接沿斑马导丝入镜。软镜进入肾盂后首先镜下观察肾盂及上、中、下各盏并定位结石,根据结石位置选用365,μm或200μm光纤,功率选择在0．5～1J、15～30Hz范围,以表面蚕蚀、周缘穿孔、中央穿孑L等方法将结石完全粉碎至2mm以内,若患者留置输尿管鞘,则以冲水引流、套石蓝取石等方法将结石取出或部分取出。所有患者常规留置double-J管2周,术后第1天拔除导尿管,术后2周拔除double-J管,术后4周常规复查泌尿系平片（KUB）或双肾CT平扫,评估结石排净率。残留结石≥4mm为有临床意义的结石残留。结果本组45例患者39例成功置放输尿管鞘,输尿管镜鞘放置成功率86．7％,进镜成功率100％,术中寻找结石成功率100％。一期手术成功碎石38例,结石均排尽或残余结石〈4mm,无需进一步处理。另2例下盏憩室内结石,2例下盏结石,3例肾乳头黏膜下钙化结石／残石均≥4mm,辅助体外冲击波碎石或2期输尿管软镜手术。结论输尿管软镜特别是最新一代的电子输尿管软镜,视野清晰、微创安全,几乎可以达到所有肾内集合系统所有位置,结合钬激光适合治疗各类复杂肾结石。     

U100激光碎石治疗输尿管结石的效果观察

目的:探讨输尿管镜下应用U100激光治疗输尿管结石的疗效。方法:对382例输尿管结石患者在输尿管镜下应用U100激光进行碎石治疗。结果:输尿管结石382例中,356例结石一次性粉碎成功,碎石成功率为93.2%。其中,输尿管上段结石一次碎石成功率为88.1%(104/118),中、下段结石一次碎石成功率为95.5%(252/264)。全部激光碎石成功的患者术后除出现血尿外,均无其他严重并发症发生。结论:U100激光碎石治疗输尿管结石具有快速、高效、安全、创伤小、操作简单等优点,可作为输尿管结石的首选治疗方法。     

Ureteral ultrasonic lithotripsy revisited: a neglected tool?

BACKGROUND AND PURPOSE: Ultrasonic lithotripsy was one of the first modalities used for treating renal and ureteral stones. However, in recent years, it has been largely replaced by newer techniques such as laser lithotripsy with rigid as well as flexible ureteroscopes. The aim of this study was to review the results and our current indications for ureteroscopic ultrasonic lithotripsy (UUL). PATIENTS AND METHODS: Between October 2000 and May 2002, 340 ureteroscopies were performed for the treatment of ureteral stones in the Rabin Medical Center. Of this series, 9 patients (2.6%) underwent UUL using a semirigid 8F ureteroscope (Wolf) and an Olympus ultrasonic lithotripter (LUS-1) with a 4.5F hollow probe. Four patients had Steinstrasse following shockwave lithotripsy, four had large (1-2-mm) ureteral stones, and one had an impacted calcified ureteral double-J stent. Stones >5 mm were initially fragmented by the holmium laser (550-microm fiber). A double-J stent was placed in all patients. The mean follow-up time was 20 months. RESULTS: The mean operative time was 84 minutes. No intraoperative complications occurred. The mean hospital stay was 3.9 days. Eight patients became stone free after the first procedure, and the other underwent secondary ureteroscopy, which rendered him stone free. CONCLUSIONS: Patients in whom UUL is performed are relatively complex stone patients. The use of ultrasonic lithotripsy following, or in combination with, laser or ballistic devices utilizes the unique properties of UUL, which combines stone fragmentation and efficient removal of small fragments. The technique was particularly useful in patients with Steinstrasse or a large stone burden. Thus, UUL has a limited but significant role in the treatment of ureteral stones.